Literature DB >> 19281331

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Scott A Harper1, John S Bradley, Janet A Englund, Thomas M File, Stefan Gravenstein, Frederick G Hayden, Allison J McGeer, Kathleen M Neuzil, Andrew T Pavia, Michael L Tapper, Timothy M Uyeki, Richard K Zimmerman.   

Abstract

Guidelines for the treatment of persons with influenza virus infection were prepared by an Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines encompass diagnostic issues, treatment and chemoprophylaxis with antiviral medications, and issues related to institutional outbreak management for seasonal (interpandemic) influenza. They are intended for use by physicians in all medical specialties with direct patient care, because influenza virus infection is common in communities during influenza season and may be encountered by practitioners caring for a wide variety of patients.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19281331      PMCID： PMC7107965          DOI： 10.1086/598513

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  215 in total

1.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

Review 2.  Neuraminidase inhibitors for influenza.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

3.  Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza.

Authors:  Michael B Rothberg; Aleta B Bonner; M Hasan Rajab; Hyun Sun Kim; Barbara W Stechenberg; David N Rose
Journal:  Clin Infect Dis       Date:  2005-11-18       Impact factor: 9.079

4.  Impact of rapid diagnosis on management of adults hospitalized with influenza.

Authors:  Ann R Falsey; Yoshihiko Murata; Edward E Walsh
Journal:  Arch Intern Med       Date:  2007-01-22

5.  Clinical study of influenza-associated rhabdomyolysis with acute renal failure.

Authors:  M Abe; T Higuchi; K Okada; K Kaizu; K Matsumoto
Journal:  Clin Nephrol       Date:  2006-09       Impact factor: 0.975

6.  Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors.

Authors:  Jason G Newland; V Matt Laurich; Anna W Rosenquist; Kateri Heydon; Daniel J Licht; Ron Keren; Theoklis E Zaoutis; Barbara Watson; Richard L Hodinka; Susan E Coffin
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

7.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.

Authors:  Anthony E Fiore; David K Shay; Karen Broder; John K Iskander; Timothy M Uyeki; Gina Mootrey; Joseph S Bresee; Nancy S Cox
Journal:  MMWR Recomm Rep       Date:  2008-08-08

8.  Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-04-27

9.  Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.

Authors:  Arnold S Monto; Jennifer L McKimm-Breschkin; Catherine Macken; Alan W Hampson; Alan Hay; Alexander Klimov; Masato Tashiro; Robert G Webster; Michelle Aymard; Frederick G Hayden; Maria Zambon
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 10.  Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do?

Authors:  Allison J McGeer
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079
View more
  238 in total

1.  Assessment of Test Performance and Potential for Environmental Contamination Associated with a Point-of-Care Molecular Assay for Group A Streptococcus in an End User Setting.

Authors:  Leslie J Donato; Nikki K Myhre; Martha A Murray; Margaret R McDonah; Jane F Myers; Julie A Maxson; Alicia M Meek; Mark J Espy; Joseph W Furst; Brad S Karon; Matthew J Binnicker
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection.

Authors:  P Li; J-F Zhang; X-D Xia; D-J Su; B-L Liu; D-L Zhao; Y Liu; D-H Zhao
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

3.  Chinese guidelines for diagnosis and treatment of influenza (2011).

Authors:  Nan-Shan Zhong; Yi-Min Li; Zi-Feng Yang; Chen Wang; You-Ning Liu; Xing-Wang Li; Yue-Long Shu; Guang-Fa Wang; Zhan-Cheng Gao; Guo-Hua Deng; Li-Xian He; Xiu-Ming Xi; Bin Cao; Kun-Ling Shen; Hao Wu; Ping-An Zhou; Qing-Quan Li
Journal:  J Thorac Dis       Date:  2011-12       Impact factor: 2.895

4.  Some observations on the evolution and new improvement of Chinese guidelines for diagnosis and treatment of influenza.

Authors:  Stephen Kw Tsui
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

5.  Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.

Authors:  Yacine Abed; Andrés Pizzorno; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 6.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

7.  Development and evaluation of a flocked nasal midturbinate swab for self-collection in respiratory virus infection diagnostic testing.

Authors:  Marek Smieja; Santina Castriciano; Susan Carruthers; Geoffrey So; Sylvia Chong; Kathy Luinstra; James B Mahony; Astrid Petrich; Max Chernesky; Mario Savarese; Daniele Triva
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

8.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Authors:  Andrés Pizzorno; Xavier Bouhy; Yacine Abed; Guy Boivin
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

9.  Improved sensitivity of a commercial reverse transcription-PCR test for subtyping of the 2009 H1N1 influenza A virus.

Authors:  Nima Mosammaparast; Richard F Rossi; Sandra Smole; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

Review 10.  2009 H1N1 influenza.

Authors:  Seth J Sullivan; Robert M Jacobson; Walter R Dowdle; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2009-12-10       Impact factor: 7.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.